Atlas Trials

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

Clinical trial NCT03487770 · COMPLETED

Trial details

NCT number
NCT03487770
Sponsor
Otsuka Beijing Research Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Autistic Disorder
Start date
2018-04-09
Primary completion
2020-04-21
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.